<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>WUXI BIOLOGICS (CAYMAN) 1 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Thu, 25 Jun 2026 19:04:15 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/wuxi%5Fbiologics%5F%28cayman%29%5F1%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>WUXI BIOLOGICS (CAYMAN) 1 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic</title><pubDate>Tue, 13 Jan 2026 04:07:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/wuxi-biologics-obtains-gmp-certification-from-uk-mhra-for-commercial-manufacturing-of-an-ophthalmic-biologic-15411096</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass">WUXI, <span class="xn-location">China, <span class="legendSpanClass"><span class="xn-chron">Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research,  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/wuxi-biologics-obtains-gmp-certification-from-uk-mhra-for-commercial-manufacturing-of-an-ophthalmic-biologic-15411096</guid></item><item><title>WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing</title><pubDate>Mon, 12 Jan 2026 14:09:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/wuxi-biologics-launches-industry-leading-digital-twin-platform-patrolab-designed-to-transform-bioprocessing-and-manufacturing-15409085</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">SHANGHAI, <span class="legendSpanClass"><span class="xn-chron">Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research,  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/wuxi-biologics-launches-industry-leading-digital-twin-platform-patrolab-designed-to-transform-bioprocessing-and-manufacturing-15409085</guid></item><item><title>WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement</title><pubDate>Mon, 05 Jan 2026 04:57:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/wuxi-biologics-achieves-iso-20400-certification-setting-benchmark-in-sustainable-procurement-15391075</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass">WUXI, <span class="xn-location">China, <span class="legendSpanClass"><span class="xn-chron">Jan. 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK) announced it has achieved ISO 20400  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/wuxi-biologics-achieves-iso-20400-certification-setting-benchmark-in-sustainable-procurement-15391075</guid></item></channel></rss>
